194 related articles for article (PubMed ID: 1723302)
21. Two monoclonal antibodies to D-dimer-specific inhibitors of fibrin polymerization.
Lugovskoy EV; Gritsenko PG; Kolesnikova IN; Zolotarova EN; Chernishov VI; Nieuwenhuizen W; Komisarenko SV
Thromb Res; 2004; 113(3-4):251-9. PubMed ID: 15140590
[TBL] [Abstract][Full Text] [Related]
22. Fibrin fragment D-dimer and fibrinogen B beta peptides in plasma as markers of clot lysis during thrombolytic therapy in acute myocardial infarction.
Lawler CM; Bovill EG; Stump DC; Collen DJ; Mann KG; Tracy RP
Blood; 1990 Oct; 76(7):1341-8. PubMed ID: 2119827
[TBL] [Abstract][Full Text] [Related]
23. A rapid latex agglutination assay for the determination of plasma fibrinogen.
Gargan PE; Sheehan C; Williams L; Ploplis V; Hearty U; Lowry C
Blood Coagul Fibrinolysis; 1990 Oct; 1(4-5):465-8. PubMed ID: 2133224
[TBL] [Abstract][Full Text] [Related]
24. A neoantigenic determinant in the D-dimer fragment of fibrin.
Lugovskoy EV; Kolesnikova IN; Gritsenko PG; Zolotareva EN; Gaffney P; Nieuwenhuizen W; Komisarenko SV
Thromb Res; 2002 Aug; 107(3-4):151-6. PubMed ID: 12431482
[TBL] [Abstract][Full Text] [Related]
25. A novel monoclonal antibody to fibrin monomer and soluble fibrin for the detection of soluble fibrin in plasma.
Hamano A; Tanaka S; Takeda Y; Umeda M; Sakata Y
Clin Chim Acta; 2002 Apr; 318(1-2):25-32. PubMed ID: 11880109
[TBL] [Abstract][Full Text] [Related]
26. New enzyme immunoassay of fibrin-fibrinogen degradation products in plasma using a monoclonal antibody.
Koopman J; Haverkate F; Koppert P; Nieuwenhuizen W; Brommer EJ; Van der Werf WG
J Lab Clin Med; 1987 Jan; 109(1):75-84. PubMed ID: 3540164
[TBL] [Abstract][Full Text] [Related]
27. A monoclonal antibody that recognizes a neo-antigen exposed in the E domain of fibrin monomer complexed with fibrinogen or its derivatives: its application to the measurement of soluble fibrin in plasma.
Soe G; Kohno I; Inuzuka K; Itoh Y; Matsuda M
Blood; 1996 Sep; 88(6):2109-17. PubMed ID: 8822930
[TBL] [Abstract][Full Text] [Related]
28. Isolation and characterization of a monoclonal antibody specific for fibrinogen and fibrin of human origin.
Sola B; Avner PR; Zilber MT; Connan F; Lévy D
Thromb Res; 1983 Mar; 29(6):643-53. PubMed ID: 6857603
[TBL] [Abstract][Full Text] [Related]
29. The importance of antibody specificity in measuring cross-linked fibrin degradation products by ELISA.
Eisenberg PR; Rylatt DB; Rusticali F; Ferrini D; Ottani F; Galvani M
Blood Coagul Fibrinolysis; 1997 Mar; 8(2):105-13. PubMed ID: 9518041
[TBL] [Abstract][Full Text] [Related]
30. Production and characterization of a monoclonal antibody reactive with a specific neoantigenic determinant (comprising B beta 54-118) in degradation products of fibrin and of fibrinogen.
Koppert PW; Koopman J; Haverkate F; Nieuwenhuizen W
Blood; 1986 Aug; 68(2):437-41. PubMed ID: 3730608
[TBL] [Abstract][Full Text] [Related]
31. Binding properties of monoclonal antibodies against human fragment D-dimer of cross-linked fibrin to human plasma clots in an in vivo model in rabbits.
Holvoet P; Stassen JM; Hashimoto Y; Spriggs D; Devos P; Collen D
Thromb Haemost; 1989 Apr; 61(2):307-13. PubMed ID: 2749602
[TBL] [Abstract][Full Text] [Related]
32. Distinct reactivity of the commercially available monoclonal antibodies of D-dimer and plasma FDP testing to the molecular variants of fibrin degradation products.
Madoiwa S; Kitajima I; Ohmori T; Sakata Y; Mimuro J
Thromb Res; 2013 Oct; 132(4):457-64. PubMed ID: 24011388
[TBL] [Abstract][Full Text] [Related]
33. Monoclonal antibodies with equal specificity to D-dimer and high-molecular-weight fibrin degradation products.
Kogan AE; Mukharyamova KS; Bereznikova AV; Filatov VL; Koshkina EV; Bloshchitsyna MN; Katrukha AG
Blood Coagul Fibrinolysis; 2016 Jul; 27(5):542-50. PubMed ID: 26656897
[TBL] [Abstract][Full Text] [Related]
34. [Preparation and characterization of McAbs against the human crosslinked fibrin degradation product D-dimer].
Qi G
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 1991 Oct; 13(5):313-6. PubMed ID: 1839247
[TBL] [Abstract][Full Text] [Related]
35. [A group of monoclonal antibodies against human fibrinogen and its fragments].
Wu XW
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 1988 Aug; 10(4):288-90. PubMed ID: 2976318
[No Abstract] [Full Text] [Related]
36. [Clinical evaluation of a test for plasma fibrin/fibrinogen degradation products (FDP) based on monoclonal anti-FDP antibody technology: an application for the scoring system of the disseminated intravascular coagulation (DIC) diagnostic criteria].
Ito K; Wada H; Abe Y; Tomatsu H; Nishioka J; Nobori T
Rinsho Byori; 2003 Apr; 51(4):295-9. PubMed ID: 12747249
[TBL] [Abstract][Full Text] [Related]
37. Immunohistochemical characterization of fibrin(ogen)-related antigens in human tissues using monoclonal antibodies.
Bini A; Mesa-Tejada R; Fenoglio JJ; Kudryk B; Kaplan KL
Lab Invest; 1989 Jun; 60(6):814-21. PubMed ID: 2659890
[TBL] [Abstract][Full Text] [Related]
38. A monoclonal antibody with high affinity for a neo-antigenic site in fibrinogen degraded by polymorphonuclear leukocyte-derived elastase.
Bos R; van Leuven CJ; Stolk J; Hiemstra PS; Dijkman JH; Nieuwenhuizen W
Blood Coagul Fibrinolysis; 1995 May; 6(3):259-67. PubMed ID: 7544637
[TBL] [Abstract][Full Text] [Related]
39. The detection of D-dimer in plasma by enzyme immunoassay: improved discrimination is obtained with a more specific signal antibody.
Hart R; Bate I; Dinh D; Elms M; Bundesen P; Hillyard C; Rylatt DB
Blood Coagul Fibrinolysis; 1994 Apr; 5(2):227-32. PubMed ID: 7519890
[TBL] [Abstract][Full Text] [Related]
40. A monoclonal antibody with ability to distinguish between NH2-terminal fragments derived from fibrinogen and fibrin.
Kudryk B; Rohoza A; Ahadi M; Chin J; Wiebe ME
Mol Immunol; 1983 Nov; 20(11):1191-200. PubMed ID: 6656769
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
